EdgarLookup

Blue Foundry Bancorp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Blue Foundry Bancorp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-0.5%
Return on Assets
Net income ÷ assets
5.93x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($10.03M) Mar 31, 2026
FY2025 Dec 31, 2024 ($11.91M) Mar 31, 2026
FY2024 Dec 31, 2023 ($7.40M) Mar 27, 2025
FY2023 Dec 31, 2022 $2.40M Mar 27, 2024
FY2021 Dec 31, 2021 ($36.34M) Mar 14, 2022
FY2021 Dec 31, 2020 ($31.51M) Mar 14, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($8.02M) Mar 31, 2026
FY2025 Dec 31, 2024 $5.06M Mar 31, 2026
FY2024 Dec 31, 2023 ($12.12M) Mar 27, 2025
FY2023 Dec 31, 2022 $2.78M Mar 27, 2024
FY2022 Dec 31, 2021 ($14.14M) Mar 30, 2023
FY2021 Dec 31, 2020 ($1.25M) Mar 14, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $140.0K Mar 27, 2025
FY2024 Dec 31, 2023 $5.57M Mar 27, 2025
FY2023 Dec 31, 2022 $5.36M Mar 27, 2024
FY2022 Dec 31, 2021 $11.90M Mar 30, 2023
FY2021 Dec 31, 2020 $7.29M Mar 14, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.17B Mar 31, 2026
FY2025 Dec 31, 2024 $2.06B Mar 31, 2026
FY2024 Dec 31, 2023 $2.04B Mar 27, 2025
FY2023 Dec 31, 2022 $2.04B Mar 27, 2024
FY2022 Dec 31, 2021 $1.91B Mar 30, 2023
FY2021 Dec 31, 2020 $1.94B Mar 14, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.86B Mar 31, 2026
FY2025 Dec 31, 2024 $1.73B Mar 31, 2026
FY2024 Dec 31, 2023 $1.69B Mar 27, 2025
FY2023 Dec 31, 2022 $1.65B Mar 27, 2024
FY2022 Dec 31, 2021 $1.48B Mar 30, 2023
FY2021 Dec 31, 2020 $1.74B Mar 14, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $312.74M Mar 31, 2026
FY2025 Dec 31, 2024 $332.20M Mar 31, 2026
FY2025 Dec 31, 2023 $355.64M Mar 31, 2026
FY2024 Dec 31, 2022 $393.72M Mar 27, 2025
FY2023 Dec 31, 2021 $429.47M Mar 27, 2024
FY2022 Dec 31, 2020 $205.60M Mar 30, 2023
FY2021 Dec 31, 2019 $237.62M Mar 14, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $142.40M Mar 31, 2026
FY2025 Dec 31, 2024 $152.43M Mar 31, 2026
FY2024 Dec 31, 2023 $164.34M Mar 27, 2025
FY2023 Dec 31, 2022 $171.76M Mar 27, 2024
FY2022 Dec 31, 2021 $169.46M Mar 30, 2023
FY2021 Dec 31, 2020 $205.80M Mar 14, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $53.14M Mar 31, 2026
FY2025 Dec 31, 2024 $42.50M Mar 31, 2026
FY2024 Dec 31, 2023 $46.03M Mar 27, 2025
FY2023 Dec 31, 2022 $41.18M Mar 27, 2024
FY2022 Dec 31, 2021 $193.45M Mar 30, 2023
FY2021 Dec 31, 2020 $316.45M Mar 14, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2024 Dec 31, 2023 0 Mar 27, 2025
FY2023 Dec 31, 2022 0 Mar 27, 2024
FY2022 Dec 31, 2021 (2) Mar 30, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2024 Dec 31, 2023 0 Mar 27, 2025
FY2023 Dec 31, 2022 0 Mar 27, 2024
FY2022 Dec 31, 2021 (2) Mar 30, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 20.76M Mar 31, 2026
FY2025 Dec 31, 2024 22.52M Mar 31, 2026
FY2024 Dec 31, 2023 24.51M Mar 27, 2025
FY2023 Dec 31, 2022 27.52M Mar 27, 2024
FY2022 Dec 31, 2021 28.52M Mar 30, 2023
FY2022 Jul 14, 2021 0 Mar 30, 2023